Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy
Efficacy of a Peri-Operative Surgical-Site, Multimodal Drug Injection in Pediatric Patients With Cerebral Palsy Undergoing Hip Surgery: A Randomized Controlled Trial
Sponsor: Northwestern University
A PHASE4 clinical study on Cerebral Palsy and Hip Dysplasia, this trial is completed. The trial is conducted by Northwestern University and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jul 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Nov 2022 — Jul 2023 [monthly]
Recruiting PHASE4
-
May 2021 — Nov 2022 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE4
-
Apr 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Apr 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Northwestern University
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .